Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Other Non-Current Liabilities (2018 - 2020)

Nephros has reported Other Non-Current Liabilities over the past 9 years, most recently at $8.2 million for Q4 2020.

  • Quarterly results put Other Non-Current Liabilities at $8.2 million for Q4 2020, up 2649.67% from a year ago — trailing twelve months through Dec 2020 was $8.2 million (up 2649.67% YoY), and the annual figure for FY2020 was $8.2 million, up 2649.67%.
  • Other Non-Current Liabilities for Q4 2020 was $8.2 million at Nephros, up from $6000.0 in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for NEPH hit a ceiling of $8.2 million in Q4 2020 and a floor of $6000.0 in Q3 2020.
  • Median Other Non-Current Liabilities over the past 3 years was $203000.0 (2020), compared with a mean of $1.1 million.
  • Peak annual rise in Other Non-Current Liabilities hit 2649.67% in 2020, while the deepest fall reached 92.31% in 2020.
  • Nephros' Other Non-Current Liabilities stood at $263000.0 in 2018, then increased by 14.07% to $300000.0 in 2019, then soared by 2649.67% to $8.2 million in 2020.
  • The last three reported values for Other Non-Current Liabilities were $8.2 million (Q4 2020), $6000.0 (Q3 2020), and $187000.0 (Q2 2020) per Business Quant data.